This week's View explores the addition of P-wave indices to improve the predictive ability of the CHA2DS2-VASc score for atrial fibrillation-related stroke risk, the effects of liraglutide on cardiovascular and safety outcomes in subgroups of patients with type 2 diabetes and chronic kidney disease, and whether percutaneous septal radiofrequency ablation can be effective treatment for patients with hypertrophic cardiomyopathy with obstruction.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, Ablation Techniques, Albuminuria, Anticoagulants, Arrhythmias, Cardiac, Atherosclerosis, Atrial Fibrillation, Atrial Remodeling, Brain Ischemia, Cardiomyopathy, Hypertrophic, Catheter Ablation, Diagnostic Imaging, Diabetes Mellitus, Type 2, Electrocardiography, Glomerular Filtration Rate, Glucagon-Like Peptide 1, Echocardiography, Exercise, Heart Failure, Kidney Failure, Chronic, Metabolic Syndrome, Myocardial Infarction, Natriuretic Peptide, Brain, Peptide Fragments, Percutaneous Coronary Intervention, Pericardial Effusion, Primary Prevention, Renal Insufficiency, Chronic, Risk, Standard of Care, Stroke, Thrombolytic Therapy, Treatment Outcome, Vascular Diseases, Ventricular Outflow Obstruction, Angiography, Pericardium

< Back to Listings